From: Ceramides: a potential therapeutic target in pulmonary emphysema
Sphingolipid | Control (n=5) | Control + Myriocin (n=9) | Elastase (n=9) | Elastase + Myriocin (n=10) |
---|---|---|---|---|
Ceramide 16:0 | 30.01 ± 6.65 | 22.23 ± 7.95 | 41.04 ± 18.77 | 21.69 ± 4.91[] |
Ceramide 18:0 | 3.13 ± 0.58 | 2.86 ± 0.75 | 4.00 ± 1.89 | 2.61 ± 0.60[] |
Ceramide 20:0 | 1.94 ± 0.47 | 1.93 ± 0.43 | 2.73 ± 1.18 | 2.02 ± 0.43 |
Ceramide 22:0 | 7.97 ± 1.67 | 7.99 ± 3.42 | 15.13 ± 7.96* | 9.11 ± 3.02[] |
Ceramide 24:0 | 37.34 ± 9.00 | 33.24 ± 13.50 | 77.75 ± 44.65* | 39.72 ± 13.00[] |
Ceramide 24:1 | 24.66 ± 7.60 | 17.33 ± 8.02 | 41.48 ± 20.83* | 19.44 ± 6.27[] |
Dihydro Ceramide 18:0 | 0.38 ± 0.21 | 0.37 ± 0.20 | 0.70 ± 0.27* | 0.44 ± 0.17[] |
Dihydro Ceramide 24:0 | 1.97 ± 1.18 | 1.83 ± 0.65 | 6.12 ± 3.94* | 3.42 ± 2.21[] |